Effects of an Inhibitor of Poly(ADP-Ribose) Polymerase, Desmethylselegiline, Trientine, and Lipoic Acid in Transgenic ALS Mice

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062 · see citing works

Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation

Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143 · see citing works

An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria

Wong, P. C., Pardo, C. A., Borchelt, D., Lee, M. K., Copeland, N. G., Jenkins, N. A., Sisodia, S. S., Cleveland, D. W., & Price, D. L. (1995) · Neuron · doi:10.1016/0896-6273(95)90259-7 · Cited by 1,439 · see citing works

ALS-Linked SOD1 Mutant G85R Mediates Damage to Astrocytes and Promotes Rapidly Progressive Disease with SOD1-Containing Inclusions

Bruijn, L. I., Becher, M. W., Lee, M. K., Anderson, K. L., Jenkins, N. A., Copeland, N. G., Sisodia, S. S., Rothstein, J. D., Borchelt, D. R., Price, D. L., et al. (1997) · Neuron · doi:10.1016/s0896-6273(00)80272-x · Cited by 1,341 · see citing works

Aggregation and Motor Neuron Toxicity of an ALS-Linked SOD1 Mutant Independent from Wild-Type SOD1

Bruijn, L. I., Houseweart, M. K., Kato, S., Anderson, K. L., Anderson, S., Ohama, E., Reaume, A. G., Scott, R. W., & Cleveland, D. W. (1998) · Science · doi:10.1126/science.281.5384.1851 · Cited by 1,231 · see citing works

Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia

Eliasson, M. J. L., Sampei, K., Mandir, A. S., Hurn, P. D., Traystman, R. J., Bao, J., Pieper, A. A., Wang, Z., Dawson, T. M., Snyder, S. H., et al. (1997) · Nature Medicine · doi:10.1038/nm1097-1089 · Cited by 1,019 · see citing works

ALS, SOD and peroxynitrite

Beckman, J. S., Carson, M. A., Smith, C. D. L., & Koppenol, W. H. (1993) · Nature · doi:10.1038/364584a0 · Cited by 876 · see citing works

Altered Reactivity of Superoxide Dismutase in Familial Amyotrophic Lateral Sclerosis

Wiedau‐Pazos, M., Goto, J. J., Rabizadeh, S., Gralla, E. B., Roe, J. A., Lee, M. K., Valentine, J. S., & Bredesen, D. E. (1996) · Science · doi:10.1126/science.271.5248.515 · Cited by 720 · see citing works

Functional Role of Caspase-1 and Caspase-3 in an ALS Transgenic Mouse Model

Li, M., Ona, V. O., Guégan, C., Chen, M., Jackson-Lewis, V. R., Andrews, L. J., Olszewski, A. J., Stieg, P. E., Lee, J.-P., Przedborski, S., et al. (2000) · Science · doi:10.1126/science.288.5464.335 · Cited by 717 · see citing works

Benefit of vitamin E, riluzole, and gababapentin in a transgenic model of familial amyotrophic lateral sclerosis

Gurney, M. E., Cutting, F. B., Zhai, P., Doble, A., Taylor, C. P., Andrus, P. K., & Hall, E. D. (1996) · Annals of Neurology · doi:10.1002/ana.410390203 · Cited by 647 · see citing works

Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase

Estévez, A. G., Crow, J. P., Sampson, J. B., Reiter, C., Zhuang, Y., Richardson, G. J., Tarpey, M. M., Barbeito, L., & Beckman, J. S. (1999) · Science · doi:10.1126/science.286.5449.2498 · Cited by 596 · see citing works

Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism

Mandir, A. S., Przedborski, S., Jackson-Lewis, V., Wang, Z.-Q., Simbulan-Rosenthal, C. M., Smulson, M. E., Hoffman, B. E., Guastella, D. B., Dawson, V. L., & Dawson, T. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5774 · Cited by 382 · see citing works

Amyotrophic lateral sclerosis: Recent insights from genetics and transgenic mice

Brown, R. H. (1995) · Cell · doi:10.1016/0092-8674(95)90346-1 · Cited by 352 · see citing works

Glyceraldehyde-3-phosphate dehydrogenase: Nuclear translocation participates in neuronal and nonneuronal cell death

Sawa, A., Khan, A. A., Hester, L. D., & Snyder, S. H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11669 · Cited by 316 · see citing works

( R )‐α‐Lipoic acid‐supplemented old rats have improved mitochondrial function, decreased oxidative damage, and increased metabolic rate

Hagen, T. M., Ingersoll, R. T., Lykkesfeldt, J., Liu, J., Wehr, C. M., Vinarsky, V., Bartholomew, J. C., & Ames, B. N. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.2.411 · Cited by 291 · see citing works

Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthase

Szabó, C., Virág, L., Cuzzocrea, S., Scott, G. S., Hake, P. W., O’Connor, M., Zingarelli, B., Salzman, A. L., & Kun, E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3867 · Cited by 262 · see citing works

Glyceraldehyde-3-phosphate Dehydrogenase, the Putative Target of the Antiapoptotic Compounds CGP 3466 and R-(−)-Deprenyl

Kragten, E. A., Lalande, I., Zimmermann, K., Roggo, S. P., Schindler, P. A., Müller, D., van Oostrum, J., Waldmeier, P. C., & Fürst, P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5821 · Cited by 209 · see citing works

Hydroxyl Radical Formation from Cuprous Ion and Hydrogen Peroxide: A Spin-Trapping Study

Gunther, M. R., Hanna, P. M., Mason, R. P., & Cohen, M. S. (1995) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1995.1068 · Cited by 191 · see citing works

Comparison of the effect of α-lipoic acid and α-tocopherol supplementation on measures of oxidative stress

Marangon, K., Devaraj, S., Tirosh, O., Packer, L., & Jialal, I. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00155-0 · Cited by 182 · see citing works

The Copper Chelator d‐Penicillamine Delays Onset of Disease and Extends Survival in a Transgenic Mouse Model of Familial Amyotrophic Lateral Sclerosis

Hottinger, A. F., Fine, E. G., Gurney, M. E., Zurn, A. D., & Aebischer, P. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01511.x · Cited by 181 · see citing works

α-Lipoic acid protects against reperfusion injury following cerebral ischemia in rats

Panigrahi, M., Sadguna, Y., Shivakumar, B. R., Kolluri, S. V. R., Roy, S., Packer, L., & Ravindranath, V. (1996) · Brain Research · doi:10.1016/0006-8993(96)00009-1 · Cited by 176 · see citing works

Reduced Apoptosis after Nerve Growth Factor and Serum Withdrawal: Conversion of Tetrameric Glyceraldehyde-3-Phosphate Dehydrogenase to a Dimer

Carlile, G. W., Chalmers-Redman, R. M. E., Tatton, N. A., Pong, A., Borden, K. L. B., & Tatton, W. G. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26436-1 · Cited by 164 · see citing works

Nuclear Localization of Overexpressed Glyceraldehyde-3-Phosphate Dehydrogenase in Cultured Cerebellar Neurons Undergoing Apoptosis

Ishitani, R., Tanaka, M., Sunaga, K., Katsube, N. C., & Chuang, D. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.4.701 · Cited by 155 · see citing works

Involvement of Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) and p53 in Neuronal Apoptosis: Evidence That GAPDH Is Upregulated by p53

Chen, R., Saunders, P. A., Wei, H., Li, Z., Seth, P. K., & Chuang, D. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-21-09654.1999 · Cited by 122 · see citing works

Neuroprotective effects of α-lipoic acid and its enantiomers demonstrated in rodent models of focal cerebral ischemia

Wolz, P., & Krieglstein, J. (1996) · Neuropharmacology · doi:10.1016/0028-3908(95)00172-7 · Cited by 95 · see citing works

Lack of apoptosis in mice with ALS

Migheli, A., Atzori, C., Piva, R., Tortarolo, M., Girelli, M., Schiffer, D., & Bendotti, C. (1999) · Nature Medicine · doi:10.1038/12381 · Cited by 93 · see citing works

Age-related changes in LTP and antioxidant defenses are reversed by an α-lipoic acid-enriched diet

McGahon, B., Martin, D. S. D., Horrobin, D. F., & Lynch, M. A. (1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00050-0 · Cited by 84 · see citing works

Benefit of a combined treatment with trientine and ascorbate in familial amyotrophic lateral sclerosis model mice

Nagano, S., Ogawa, Y., Yanagihara, T., & Sakoda, S. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00227-x · Cited by 81 · see citing works

Protection against peroxynitrite‐dependent tyrosine nitration and α1‐antiproteinase inactivation by oxidized and reduced lipoic acid

Whiteman, M., Tritschler, H., & Halliwell, B. B. (1996) · FEBS Letters · doi:10.1016/0014-5793(95)01489-6 · Cited by 81 · see citing works

Deprenyl and Desmethylselegiline Protect Mesencephalic Neurons from Toxicity Induced by Glutathione Depletion

Mytilineou, C., Leonardi, E. T. K., Radcliffe, P. M., Heinonen, E. H., Han, S.-K., Werner, P., Cohen, G., & Olanow, C. W. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37288-x · Cited by 80 · see citing works

Selegiline Is Ineffective in a Collaborative Double-blind, Placebo-Controlled Trial for Treatment of Amyotrophic Lateral Sclerosis

Lange, D. J., Murphy, P. L., Diamond, B. E., Appel, V., Lai, E. C., Younger, D. S., & Appel, S. H. (1998) · Archives of Neurology · doi:10.1001/archneur.55.1.93 · Cited by 73 · see citing works

l ‐(−)‐Desmethylselegiline, a Metabolite of Selegiline [ l ‐(−)‐Deprenyl], Protects Mesencephalic Dopamine Neurons from Excitotoxicity In Vitro

Mytilineou, C., Radcliffe, P. M., & Olanow, C. W. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68010434.x · Cited by 71 · see citing works

Protective effects of 5-iodo-6-amino-1,2-benzopyrone, an inhibitor of poly(ADP-ribose) synthetase against peroxynitrite-induced glial damage and stroke development

Endres, M., Scott, G. S., Salzman, A. L., Kun, E., Moskowitz, M. A., & Szabó, C. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00381-1 · Cited by 47 · see citing works

Functional dissection ofdrosophila capricious: its novel roles in neuronal pathfinding and selective synapse formation

Taniguchi, H., Shishido, E., Takeichi, M., & Nose, A. (2000) · Journal of Neurobiology · doi:10.1002/(sici)1097-4695(200001)42:1 · Cited by 35 · see citing works

SUPPRESSION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS BY ADMINISTRATION OF 5-IODO-6-AMINO-1,2,BENZOPYRONE, A NOVEL INHIBITOR OF POLY (ADP-RIBOSE) SYNTHETASE

Scott, G. S., Hake, P. W., Salzman, A. L., & Szabó, C. (1998) · Critical Care Medicine · doi:10.1097/00003246-199801001-00046 · Cited by 6 · see citing works

Role of Free Radicals in the Neurodegenerative Diseases: Therapeutic Implications for Antioxidant Treatment

Halliwell, B. (2001) · Drugs & Aging · doi:10.2165/00002512-200118090-00004 · Cited by 1,502 · see citing works

From charcot to lou gehrig: deciphering selective motor neuron death in als

Cleveland, D. W., & Rothstein, J. D. (2001) · Nature reviews. Neuroscience · doi:10.1038/35097565 · Cited by 1,389 · see citing works

Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS

Turner, B. J., & Talbot, K. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.01.001 · Cited by 495 · see citing works

Excitotoxic and Excitoprotective Mechanisms: Abundant Targets for the Prevention and Treatment of Neurodegenerative Disorders

Mattson, M. P. (2003) · NeuroMolecular Medicine · doi:10.1385/nmm:3:2:65 · Cited by 475 · see citing works

Modification of Brain Aging and Neurodegenerative Disorders by Genes, Diet, and Behavior

Mattson, M. P., Chan, S. L., & Duan, W. (2002) · Physiological Reviews · doi:10.1152/physrev.00004.2002 · Cited by 438 · see citing works

Mitochondrial Diseases of the Brain

Chaturvedi, R. K., & Beal, M. F. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.03.018 · Cited by 416 · see citing works

Role of manganese in neurodegenerative diseases

Bowman, A. B., Kwakye, G. F., Hernández, E. H., & Aschner, M. (2011) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2011.08.144 · Cited by 392 · see citing works

Manganese in Health and Disease

Ávila, D. S., Puntel, R. L., & Aschner, M. (2013) · Metal ions in life sciences · doi:10.1007/978-94-007-7500-8_7 · Cited by 358 · see citing works

Dysregulation of Glutathione Homeostasis in Neurodegenerative Diseases

Johnson, W. M., Wilson‐Delfosse, A. L., & Mieyal, J. J. (2012) · Nutrients · doi:10.3390/nu4101399 · Cited by 354 · see citing works

Lost in translation: Treatment trials in the SOD1 mouse and in human ALS

Benatar, M. G. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.12.015 · Cited by 352 · see citing works

Copper Dyshomeostasis in Neurodegenerative Diseases—Therapeutic Implications

Gromadzka, G., Tarnacka, B., Flaga, A., & Adamczyk, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239259 · Cited by 339 · see citing works

A review of specific dietary antioxidants and the effects on biochemical mechanisms related to neurodegenerative processes

Esposito, E., Rotilio, D., DIMATTEO, V., Giulio, C. D., Cacchio, M., & Algeri, S. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00078-7 · Cited by 327 · see citing works

Mitochondrial Approaches for Neuroprotection

Chaturvedi, R. K., & Beal, M. F. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.027 · Cited by 294 · see citing works

Antioxidants as treatment for neurodegenerative disorders

Moosmann, B., & Behl, C. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.10.1407 · Cited by 253 · see citing works

The transition metals copper and iron in neurodegenerative diseases

Rivera-Mancía, S., Pérez‐Neri, I., Rı́os, C., Tristán-López, L. A., Rivera-Espinosa, L., & Montes, S. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.04.010 · Cited by 243 · see citing works

Mitochondria in Amyotrophic Lateral Sclerosis: A Trigger and a Target

Dupuis, L., de Aguilar, J. G., Oudart, H., de Tapia, M., Barbeito, L., & Loeffler, J. (2004) · Neurodegenerative Diseases · doi:10.1159/000085063 · Cited by 150 · see citing works

Manganese toxicity in the central nervous system: the glutamine/glutamate‐γ‐aminobutyric acid cycle

Sidoryk‐Wȩgrzynowicz, M., & Aschner, M. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12040 · Cited by 129 · see citing works

Redox metals homeostasis in multiple sclerosis and amyotrophic lateral sclerosis: a review

Sheykhansari, S., Kozielski, K., Bill, J., Sitti, M., Gemmati, D., Zamboni, P., & Singh, A. V. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0379-2 · Cited by 120 · see citing works

Copper, Iron, and Manganese Toxicity in Neuropsychiatric Conditions

Tarnacka, B., Jopowicz, A., & Maślińska, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157820 · Cited by 116 · see citing works

Nuclear poly(ADP-ribose) activity is a therapeutic target in amyotrophic lateral sclerosis

McGurk, L., Mojsilovic‐Petrovic, J., Deerlin, V. M. V., Shorter, J., Kalb, R. G., Lee, V. M., Trojanowski, J. Q., Lee, E. B., & Bonini, N. M. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0586-1 · Cited by 112 · see citing works

Neurodegeneration and Inflammation

DeLegge, M. H., & Smoke, A. (2008) · Nutrition in Clinical Practice · doi:10.1177/011542650802300135 · Cited by 114 · see citing works

Prospects for antiapoptotic drug therapy of neurodegenerative diseases

Waldmeier, P. C. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00025-3 · Cited by 105 · see citing works

Chelation therapy for neurodegenerative diseases

Bolognin, S., Drago, D., Luigi Messori, A., & Zatta, P. F. (2009) · Medicinal Research Reviews · doi:10.1002/med.20148 · Cited by 97 · see citing works

An in vitro screening cascade to identify neuroprotective antioxidants in ALS

Barber, S. C., Higginbottom, A., Mead, R. J., Barber, S., & Shaw, P. J. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.01.019 · Cited by 95 · see citing works

CuII(atsm) improves the neurological phenotype and survival of SOD1G93A mice and selectively increases enzymatically active SOD1 in the spinal cord

Hilton, J. B. W., Mercer, S. W., Lim, N. K.-H., Faux, N. G., Buncic, G., Beckman, J. S., Roberts, B. R., Donnelly, P. S., White, A. R., & Crouch, P. J. (2017) · Scientific Reports · doi:10.1038/srep42292 · Cited by 94 · see citing works

Copper homeostasis and cuproptosis in health and disease

Yang, Y., Wu, J., Wang, L., Ji, G., & Dang, Y. (2024) · MedComm · doi:10.1002/mco2.724 · Cited by 91 · see citing works

Folic acid protects motor neurons against the increased homocysteine, inflammation and apoptosis in SOD1G93A transgenic mice

Zhang, X., Chen, S., Li, L., Wang, Q., & Le, W. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.02.020 · Cited by 88 · see citing works

Down-regulation of microglial activation may represent a practical strategy for combating neurodegenerative disorders

McCarty, M. F. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.01.013 · Cited by 87 · see citing works

Dysregulation of intracellular copper homeostasis is common to transgenic mice expressing human mutant superoxide dismutase-1s regardless of their copper-binding abilities

Tokuda, E., Okawa, E., Watanabe, S., Ono, S.-I., & Marklund, S. L. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.01.001 · Cited by 83 · see citing works

The efficacy of trientine or ascorbate alone compared to that of the combined treatment with these two agents in familial amyotrophic lateral sclerosis model mice

Nagano, S., Fujii, Y., Yamamoto, T., Taniyama, M., Fukada, K., Yanagihara, T., & Sakoda, S. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(02)00014-6 · Cited by 83 · see citing works

Inhibition of glycogen synthase kinase-3 suppresses the onset of symptoms and disease progression of G93A-SOD1 mouse model of ALS

Koh, S., Kim, Y., Kim, H. Y., Hwang, S., Lee, C. H., & Kim, S. H. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.03.004 · Cited by 83 · see citing works

Small molecule modulation of a redox-sensitive stress granule protein dissolves stress granules with beneficial outcomes for familial amyotrophic lateral sclerosis modelsPreprint

Uechi, H., Sridharan, S., Nijssen, J., Bilstein, J., Iglesias‐Artola, J. M., Kishigami, S., Casablancas-Antràs, V., Poser, I., Martinez, E. J., Boczek, E. E., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/721001 · Cited by 82 · see citing works

Copper Homeostasis as a Therapeutic Target in Amyotrophic Lateral Sclerosis with SOD1 Mutations

Tokuda, E., & Furukawa, Y. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050636 · Cited by 77 · see citing works

Nicotinamide Adenine Dinucleotide Metabolism and Neurodegeneration

Pehar, M., Harlan, B. A., Killoy, K. M., & Vargas, M. R. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7145 · Cited by 77 · see citing works

Metallothionein proteins expression, copper and zinc concentrations, and lipid peroxidation level in a rodent model for amyotrophic lateral sclerosis

Tokuda, E., Ono, S.-I., Ishige, K., Naganuma, A., Ito, Y., & Suzuki, T. (2006) · Toxicology · doi:10.1016/j.tox.2006.09.011 · Cited by 76 · see citing works

Nutrition and Dietary Supplements in Motor Neuron Disease

Rosenfeld, J., & Ellis, A. C. (2008) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/j.pmr.2008.03.001 · Cited by 72 · see citing works

Ammonium tetrathiomolybdate delays onset, prolongs survival, and slows progression of disease in a mouse model for amyotrophic lateral sclerosis

Tokuda, E., Ono, S.-I., Ishige, K., Watanabe, S., Okawa, E., Ito, Y., & Suzuki, T. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.05.011 · Cited by 72 · see citing works

Evaluation of the NAD+ biosynthetic pathway in ALS patients and effect of modulating NAD+ levels in hSOD1-linked ALS mouse models

Harlan, B. A., Killoy, K. M., Pehar, M., Liu, L., Auwerx, J. H., & Vargas, M. R. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113219 · Cited by 70 · see citing works

Dysregulation of intracellular copper trafficking pathway in a mouse model of mutant copper/zinc superoxide dismutase‐linked familial amyotrophic lateral sclerosis

Tokuda, E., Okawa, E., & Ono, S. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06310.x · Cited by 68 · see citing works

Reduced creatine kinase activity in transgenic amyotrophic lateral sclerosis mice

Wendt, S., Dedeoglu, A., Speer, O., Wallimann, T., Beal, M. F., & Andreassen, O. A. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00784-0 · Cited by 65 · see citing works

Galactooligosaccharide improves the animal survival and alleviates motor neuron death in SOD1G93A mouse model of amyotrophic lateral sclerosis

Song, L., Gao, Y., Zhang, X., & Le, W. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.05.002 · Cited by 63 · see citing works

Nutritional issues and supplements in amyotrophic lateral sclerosis and other neurodegenerative disorders

Cameron, A., & Rosenfeld, J. (2002) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200211000-00005 · Cited by 62 · see citing works

Insights into the mechanisms of copper dyshomeostasis in amyotrophic lateral sclerosis

Gil-Bea, F. J., Aldanondo, G., Lasa-Fernández, H., de Munaín, A. L., & Vallejo‐Illarramendi, A. (2017) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2017.9 · Cited by 57 · see citing works

A Metadata Analysis of Oxidative Stress Etiology in Preclinical Amyotrophic Lateral Sclerosis: Benefits of Antioxidant Therapy

Bond, L., Bernhardt, K. D., Madria, P., Sorrentino, K., Scelsi, H. F., & Mitchell, C. S. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00010 · Cited by 57 · see citing works

PARP Expression Is Increased in Astrocytes but Decreased in Motor Neurons in the Spinal Cord of Sporadic ALS Patients

Kim, S. H., Henkel-Tigges, J., Beers, D. R., Şengün, İ. Ş., Simpson, E. P., Goodman, J. C., Engelhardt, J. I., Siklós, L., & Appel, S. H. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.1.88 · Cited by 56 · see citing works

The lipophilic metal chelators DP‐109 and DP‐460 are neuroprotective in a transgenic mouse model of amyotrophic lateral sclerosis

Petri, S., Calingasan, N. Y., Alsaied, O. A., Wille, E., Kiaei, M., Friedman, J. E., Baranova, O., Chavez, J. C., & Beal, M. F. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04604.x · Cited by 55 · see citing works

Nutritional and exercise-based interventions in the treatment of amyotrophic lateral sclerosis

Patel, B. P., & Hamadeh, M. J. (2009) · Clinical Nutrition · doi:10.1016/j.clnu.2009.06.002 · Cited by 55 · see citing works

PGC-1α, Sirtuins and PARPs in Huntington’s Disease and Other Neurodegenerative Conditions: NAD+ to Rule Them All

Lloret, A., & Beal, M. F. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02809-1 · Cited by 52 · see citing works

Oxidative Stress Treatment for Clinical Trials in Neurodegenerative Diseases

Ienco, E. C., LoGerfo, A., Carlesi, C., Orsucci, D., Ricci, G., Mancuso, M., & Siciliano, G. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110164 · Cited by 54 · see citing works

Overexpression of metallothionein-I, a copper-regulating protein, attenuates intracellular copper dyshomeostasis and extends lifespan in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase-1

Tokuda, E., Okawa, E., Watanabe, S., & Ono, S.-I. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt517 · Cited by 48 · see citing works

Recombinant human erythropoietin suppresses symptom onset and progression of G93A‐SOD1 mouse model of ALS by preventing motor neuron death and inflammation

Koh, S., Kim, Y., Kim, H. Y., Cho, G. W., Kim, K. S., & Kim, S. H. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05471.x · Cited by 47 · see citing works

α-Lipoic acid attenuates oxidative stress and neurotoxicity via the ERK/Akt-dependent pathway in the mutant hSOD1 related Drosophila model and the NSC34 cell line of amyotrophic lateral sclerosis

Wang, T., Cheng, J., Wang, S., Wang, X., Jiang, H., Yang, Y., Wang, Y., Zhang, C., Liang, W., & Feng, H. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.05.019 · Cited by 43 · see citing works

Roles of vitamin D in amyotrophic lateral sclerosis: possible genetic and cellular signaling mechanisms

Lương, K. V. Q., & Nguyễn, L. (2013) · Molecular Brain · doi:10.1186/1756-6606-6-16 · Cited by 37 · see citing works

Toward prevention of alzheimers disease – Potential nutraceutical strategies for suppressing the production of amyloid beta peptides

McCarty, M. F. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.04.067 · Cited by 37 · see citing works

One Universal Common Endpoint in Mouse Models of Amyotrophic Lateral Sclerosis

Solomon, J. A., Tarnopolsky, M. A., & Hamadeh, M. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020582 · Cited by 32 · see citing works

Reactive astrocytes express PARP in the central nervous system of SODG93A transgenic mice

Chung, Y. H., Joo, K. M., Lee, Y. J., Shin, D. H., & Ik, C. (2004) · Brain Research · doi:10.1016/j.brainres.2004.01.010 · Cited by 27 · see citing works

Therapies in amyotrophic lateral sclerosis–beyond riluzole

Morrison, K. E. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(02)00169-8 · Cited by 26 · see citing works

(r)-, but not (s)-alpha lipoic acid stimulates deficient brain pyruvate dehydrogenase complex in vascular dementia, but not in Alzheimer dementia

Fr�lich, L., G�tz, M. E., Weinm�ller, M., Youdim, M. B. H., Barth, N., Dirr, A., Gsell, W., Jellinger, K. A., Beckmann, H., & Riederer, P. F. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-003-0043-5 · Cited by 26 · see citing works

Amyotrophic Lateral Sclerosis

Dib, M. (2003) · Drugs · doi:10.2165/00003495-200363030-00004 · Cited by 24 · see citing works

Therapeutic developments in the treatment of amyotrophic lateral sclerosis

Jackson, M. T., Lladó, J., & Rothstein, J. D. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.10.1343 · Cited by 23 · see citing works

Antioxidant strategies based on tomato-enriched food or pyruvate do not affect disease onset and survival in an animal model of amyotrophic lateral sclerosis

Esposito, E., Capasso, M., Tomasso, N. N. D., Corona, C., Pellegrini, F., Uncini, A., Vitaglione, P., Fogliano, V., Piantelli, M., & Sensi, S. L. (2007) · Brain Research · doi:10.1016/j.brainres.2007.06.095 · Cited by 22 · see citing works

Psychotropic and Neurotropic Activity

Vogel, H. G. (2007) · Springer eBooks · doi:10.1007/978-3-540-70995-4_6 · Cited by 20 · see citing works

Copper homeostasis and cuproptosis: implications for neurodegenerative diseases

Tao, F., Lin, M., Meng, X., Huang, L., Zhuo, B., Jiang, S., Deng, S., Meng, Z., & Shi, J. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1688554 · Cited by 18 · see citing works

Nicotinamide Adenine Dinucleotide (NAD + )-Dependent Signaling in Neurological Disorders

Bresque, M., Esteve, D., Pehar, M., & Vargas, M. R. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0241 · Cited by 12 · see citing works

Prevention and Therapy of Neurodegenerative Disorders: Role of Nutritional Antioxidants

Matteo, V. D., Pierucci, M., Giovanni, G. D., & Esposito, E. (2007) · Elsevier eBooks · doi:10.1016/b978-044452809-4/50168-x · Cited by 11 · see citing works

From copper homeostasis to cuproptosis: a new perspective on CNS immune regulation and neurodegenerative diseases

Li, L., Lv, L., Wang, Z., Liu, X., Wang, Q., Zhu, H., Jiang, B., Han, Y., Pan, X., Zhou, X., et al. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1581045 · Cited by 9 · see citing works

Stress-induced nuclear GAPDH: Scientific update and clinical application

Vedula, P., Ishizuka, K., Hayashida, A., Sueo, K., & Sawa, A. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00725 · Cited by 9 · see citing works

The Role of Caffeine in Neurodegenerative Diseases

Lương, K. V. Q., & Nguyễn, L. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-411462-3.00028-x · Cited by 5 · see citing works

Animal Models of Neurological Disorders

Deshmukh, R., & Bansal, P. (2017) · Springer eBooks · doi:10.1007/978-981-10-5981-0 · Cited by 5 · see citing works

Copper in Brain and Neurodegeneration

Liddell, J. R., Bush, A. I., & White, A. R. (2004) · Encyclopedia of Inorganic and Bioinorganic Chemistry · doi:10.1002/9781119951438.eibc2143 · Cited by 5 · see citing works

Mechanisms of Excitotoxicity and Excitoprotection

Mattson, M. P. (2004) · Springer eBooks · doi:10.1007/978-1-4419-8959-8_7 · Cited by 4 · see citing works

Alpha-Lipoic Acid and Biotin in Neurodegenerative Diseases: Convergent Mechanistic Insights from Preclinical Models to Clinical Perspectives

Aguilera‐Méndez, A., Aguilera-Manuel, K., Saavedra‐Molina, A., Ríos‐Chávez, P., Villafaña, S., Nieto-Aguilar, R., Godínez‐Hernández, D., Ortega-Cuéllar, D., Palomera‐Sánchez, Z., & Gauthereau‐Torres, M. Y. (2026) · Neurology International · doi:10.3390/neurolint18040064 · Cited by 3 · see citing works

Transcranial Focused Ultrasound Modifies Disease Progression in SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis

Hong, Z., Yi, S., Deng, M., Zhong, Y., Zhao, Y., Li, L., Zhou, H., Xiao, Y., Hu, X., & Niu, L. (2025) · IEEE Transactions on Ultrasonics Ferroelectrics and Frequency Control · doi:10.1109/tuffc.2024.3525143 · Cited by 3 · see citing works

Chapter 21 Disease-Modifying Therapies in Motor Neuron Disorders: The Present Position and Potential Future Developments

Turner, M. R., & Leigh, P. N. (2003) · Blue books of practical neurology · doi:10.1016/s1877-3419(09)70122-9 · Cited by 3 · see citing works

Preclinical testing of potential therapeutics for Amyotrophic Lateral Sclerosis

Kaneb, H. (2012) · Spiral (Imperial College London) · doi:10.25560/9606 · Cited by 3 · see citing works

Role of Nutritional Antioxidants in the Prevention and Treatment of Neurodegenerative Disorders

Esposito, E. (2006) · Nutrition and disease prevention · doi:10.1201/9781420019131.ch5 · Cited by 2 · see citing works

Animal Models of Neurological Disorders

Kallman, M. J. (2016) · Springer eBooks · doi:10.1007/978-3-642-27728-3_33-2 · Cited by 2 · see citing works

Role of Poly(ADP-ribose) Polymerase in Brain Inflammation and Neuroinjury

Scott, G. S., Komjáti, K., Besson, V. C., & Szabó, C. (2007) · Springer eBooks · doi:10.1007/978-0-387-30398-7_20 · Cited by 2 · see citing works

ALSUntangled #79: alpha-lipoic acid

Giacobbe, A., Hiana, J. C., Wang, O., Benatar, M. G., Wicks, P. J., Cadavid, J. M., Jhooty, S., McDermott, C. J., Pattee, G. L., Bertorini, T. E., et al. (2025) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2025.2507166 · Cited by 1 · see citing works

Neuroprotective mechanisms of valproic acid and alpha-lipoic acid in ALS: a network pharmacology-based investigation

Zhang, D., Han, L., Zhang, W., Wang, D., Huo, D., Tan, X., Su, X., Wang, M., Xu, J., Cheng, J., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1681929 · Cited by 1 · see citing works

Potential Therapies for Mitochondrial Dysfunction

Henchcliffe, C., & Beal, M. F. (2011) · Springer eBooks · doi:10.1007/978-0-85729-701-3_13 · Cited by 1 · see citing works

Chapter 19 Therapies in amyotrophic lateral sclerosis: Options for the near and far future

Lemmens, R., Bosch, L. V. D., & Robberecht, W. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)80022-4 · Cited by 1 · see citing works

Animal Models of Neurological Disorders

Kallman, M. J. (2015) · Springer eBooks · doi:10.1007/978-3-319-05392-9_33 · Cited by 1 · see citing works

Advances in Neuroprotection Research for Neurodegenerative Diseases

Götz, M. E., & Riederer, P. F. (2004) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-8969-7_1 · Cited by 1 · see citing works

Chapter 9 Cellular Biological Effects of Copper/Zinc Superoxide Dismutase Mutations

(2003) · Blue books of practical neurology · doi:10.1016/s1877-3419(09)70110-2

Die Rolle von Mangan bei neurodegenerativen Erkrankungen

Bowman, A. B., Kwakye, G. F., Hernández, E. H., & Aschner, M. (2013) · Perspectives in Medicine · doi:10.1016/j.permed.2011.08.001

Antioxidants and Anti-Inflammatory Drugs in the Treatment of Motor Neuron Disease

Esmaeili, M. A., & Kiaei, M. (2014) · Springer eBooks · doi:10.1007/978-3-642-30018-9_132

Astrocytes release small molecules to protect neurons from oxidative stress

Wang, X. (2009) · cIRcle (University of British Columbia) · doi:10.14288/1.0090451

METALLOTHIONEINS AND NEURODEGENERATIVE DISEASES

Bolognin, S., & Zatta, P. F. (2008) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789812778949_0003

Animal Models of Neurological Disorders

Kallman, M. J. (2015) · Springer eBooks · doi:10.1007/978-3-642-27728-3_33-1

Nutraceuticals and phytotherapeutics for holistic management of amyotrophic lateral sclerosis

Katiyar, D., Singhal, S., Bansal, P., Nagarajan, K., & Grover, P. (2023) · 3 Biotech · doi:10.1007/s13205-023-03475-5 · Cited by 1 · see citing works

Interplay between Neuronal Metabolism and Signaling in Model Systems with Impaired α-Ketoglutarate Dehydrogenase Complex Activity

Kokas, M., Ambrus, A., Tretter, L., & Komlódi, T. (2026) · Biochemistry (Moscow) · doi:10.1134/s0006297926600663

Copper Homeostasis and Cuproptosis in Neurodegenerative Diseases

Liu, B., Zhang, L., Lv, B., Xu, C., Han, L., Yan, Q., & Wang, X. (2026) · Cells · doi:10.3390/cells15141238

Metal Ions and Protein Aggregation: Unraveling Molecular Interactions and Theranostic Prospects in Proteinopathies

Milardi, D., Han, J., Lee, H. J., Ding, F., Miller, Y., Faller, P., Bush, A. I., Crouch, P. J., Finkelstein, D. I., Double, K. L., et al. (2026) · Chemical Reviews · doi:10.1021/acs.chemrev.5c00420

Cuproptosis-related genes reveal related typing, prognosis, and immunological features of amyotrophic lateral sclerosis: A comprehensive landscape assessed through machine learning algorithms, risk model construction, and verification

Gong, Z., & Wei, B. (2026) · Journal of Genetic Engineering and Biotechnology · doi:10.1016/j.jgeb.2026.100835

The lipophilic metal chelators DP‐109 and DP‐460 are neuroprotective in a transgenic mouse model of amyotrophic lateral sclerosis

Petri, S., Calingasan, N. Y., Alsaied, O. A., Wille, E., Kiaei, M., Friedman, J. E., Baranova, O., Chavez, J. C., & Beal, M. F. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04604.x · Cited by 55 · see citing works

Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis

Petri, S., Kiaei, M., Kipiani, K., Chen, J., Calingasan, N. Y., Crow, J. P., & Beal, M. F. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.09.013 · Cited by 161 · see citing works

New Strategy That Delays Progression of Amyotrophic Lateral Sclerosis in G1H-G93A Transgenic Mice: Oral Administration of Xanthine Oxidoreductase Inhibitors That Are Not Substrates for the Purine Salvage Pathway

Kato, S., Kato, M., Kusano, T., & Nishino, T. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw088 · Cited by 20 · see citing works

dl-3-n-butylphthalide extends survival by attenuating glial activation in a mouse model of amyotrophic lateral sclerosis

Feng, X., Peng, Y., Liu, M., & Cui, L. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.10.009 · Cited by 91 · see citing works

The Oral Antidiabetic Pioglitazone Protects from Neurodegeneration and Amyotrophic Lateral Sclerosis-Like Symptoms in Superoxide Dismutase-G93A Transgenic Mice

Schütz, B., Reimann, J., Dumitrescu‐Ozimek, L., Kappes‐Horn, K., Landreth, G. E., Schürmann, B., Zimmer, A., & Heneka, M. T. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2038-05.2005 · Cited by 225 · see citing works